Scotiabank Has Bearish Estimate for SQM FY2025 Earnings

Sociedad Química y Minera de Chile S.A. (NYSE:SQM) – Equities researchers at Scotiabank dropped their FY2025 earnings per share estimates for Sociedad Química y Minera de Chile in a research note issued on Monday, March 10th. Scotiabank analyst B. Isaacson now forecasts that the basic materials company will post earnings per share of $2.78 for the year, down from their previous estimate of $3.92. Scotiabank currently has a “Sector Outperform” rating and a $50.00 price target on the stock. The consensus estimate for Sociedad Química y Minera de Chile’s current full-year earnings is ($1.31) per share. Scotiabank also issued estimates for Sociedad Química y Minera de Chile’s FY2026 earnings at $4.49 EPS.

Sociedad Química y Minera de Chile (NYSE:SQM) last announced its earnings results on Tuesday, March 4th. The basic materials company reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.10). Sociedad Química y Minera de Chile had a positive return on equity of 16.12% and a negative net margin of 6.74%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.01 billion.

Other equities analysts also recently issued research reports about the stock. StockNews.com upgraded shares of Sociedad Química y Minera de Chile to a “sell” rating in a research note on Thursday, November 21st. Deutsche Bank Aktiengesellschaft cut their price target on shares of Sociedad Química y Minera de Chile from $35.00 to $31.00 and set a “hold” rating on the stock in a research note on Thursday, November 21st. Two analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, Sociedad Química y Minera de Chile presently has an average rating of “Hold” and a consensus target price of $45.56.

Sociedad Química y Minera de Chile Stock Performance

Shares of Sociedad Química y Minera de Chile stock opened at $42.67 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.94 and a quick ratio of 2.05. The stock has a market capitalization of $12.19 billion, a price-to-earnings ratio of -38.44, a price-to-earnings-growth ratio of 5.00 and a beta of 1.08. The business has a 50-day moving average of $39.24 and a 200 day moving average of $38.94. Sociedad Química y Minera de Chile has a 12 month low of $32.24 and a 12 month high of $51.90.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of SQM. Manning & Napier Advisors LLC bought a new position in shares of Sociedad Química y Minera de Chile during the fourth quarter valued at approximately $120,395,000. Nuveen Asset Management LLC bought a new stake in shares of Sociedad Química y Minera de Chile in the 4th quarter worth approximately $35,832,000. Northern Trust Corp boosted its position in Sociedad Química y Minera de Chile by 367.9% during the 4th quarter. Northern Trust Corp now owns 293,799 shares of the basic materials company’s stock valued at $10,683,000 after purchasing an additional 231,010 shares during the period. Woodline Partners LP bought a new position in Sociedad Química y Minera de Chile during the 4th quarter worth $7,314,000. Finally, Van ECK Associates Corp increased its position in Sociedad Química y Minera de Chile by 28.4% in the fourth quarter. Van ECK Associates Corp now owns 804,913 shares of the basic materials company’s stock worth $29,267,000 after buying an additional 177,898 shares during the period. Hedge funds and other institutional investors own 12.41% of the company’s stock.

Sociedad Química y Minera de Chile Company Profile

Sociedad Química y Minera de Chile SA operates as a mining company worldwide. The company offers specialty plant nutrients, including sodium potassium nitrate, specialty blends, and other specialty fertilizers under Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, ProP, and Prohydric brands. It also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders.